Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hoppensteadt

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 1, 1993
Pharmacological profile of reviparin-sodiumD Hoppensteadt, W Jeske, J Fareed
Seminars in Thrombosis and Hemostasis|January 1, 1995
Comparative studies on the anticoagulant and protease generation inhibitory actions of newly developed site-directed thrombin inhibitory drugs. Efegatran, argatroban, hirulog, and hirudinD D Callas, D Hoppensteadt, J Fareed
Seminars in Thrombosis and Hemostasis|January 1, 1991
Protamine sulfate neutralization of lactobionic acid amidesD Hoppensteadt, J M Walenga, J Fareed
Seminars in Thrombosis and Hemostasis|October 1, 1984
Laboratory application of radioimmunoassay in the quantitation of molecular markers of hemostatic activationJ M Walenga, J Fareed, D Hoppensteadt
Thrombosis Research. Supplement|January 1, 1991
Laboratory monitoring of the clinical effects of low molecular weight heparinsJ M Walenga, D Hoppensteadt, J Fareed
Drugs & Aging|September 1, 1992
Low molecular weight heparins. An objective overviewD Hoppensteadt, J M Walenga, J Fareed
Thrombosis Research|November 1, 1990
Comparative antithrombotic and hemorrhagic effects of dermatan sulfate, heparan sulfate and heparinD Hoppensteadt, J M Walenga, J Fareed
Seminars in Thrombosis and Hemostasis|January 1, 1991
Non-heparin glycosaminoglycan-derived drugs: a biochemical and pharmacologic perspectiveJ M Walenga, D Hoppensteadt, J Fareed
Thrombosis Research|October 29, 1998
Modulation of vasoconstriction by clopidogrel and ticlopidineL H Yang, D Hoppensteadt, J Fareed
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 1, 1995
Measurement of functional and immunologic levels of tissue factor pathway inhibitor. Some methodologic considerationsW Jeske, D Hoppensteadt, J Fareed, et al.
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 1, 1993
Pharmacological profile of reviparin-sodiumD Hoppensteadt, W Jeske, J Fareed
Seminars in Thrombosis and Hemostasis|January 1, 1995
Comparative studies on the anticoagulant and protease generation inhibitory actions of newly developed site-directed thrombin inhibitory drugs. Efegatran, argatroban, hirulog, and hirudinD D Callas, D Hoppensteadt, J Fareed
Seminars in Thrombosis and Hemostasis|January 1, 1991
Protamine sulfate neutralization of lactobionic acid amidesD Hoppensteadt, J M Walenga, J Fareed
Seminars in Thrombosis and Hemostasis|October 1, 1984
Laboratory application of radioimmunoassay in the quantitation of molecular markers of hemostatic activationJ M Walenga, J Fareed, D Hoppensteadt
Thrombosis Research. Supplement|January 1, 1991
Laboratory monitoring of the clinical effects of low molecular weight heparinsJ M Walenga, D Hoppensteadt, J Fareed
Drugs & Aging|September 1, 1992
Low molecular weight heparins. An objective overviewD Hoppensteadt, J M Walenga, J Fareed
Thrombosis Research|November 1, 1990
Comparative antithrombotic and hemorrhagic effects of dermatan sulfate, heparan sulfate and heparinD Hoppensteadt, J M Walenga, J Fareed
Seminars in Thrombosis and Hemostasis|January 1, 1991
Non-heparin glycosaminoglycan-derived drugs: a biochemical and pharmacologic perspectiveJ M Walenga, D Hoppensteadt, J Fareed
Thrombosis Research|October 29, 1998
Modulation of vasoconstriction by clopidogrel and ticlopidineL H Yang, D Hoppensteadt, J Fareed
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 1, 1995
Measurement of functional and immunologic levels of tissue factor pathway inhibitor. Some methodologic considerationsW Jeske, D Hoppensteadt, J Fareed, et al.
Pageof 11